ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,630, issued on July 15, was assigned to Novartis AG (Basel, Switzerland).
"Ceritinib formulation" was invented by Sebastien Breulles (Nevers, France) and Simon Ensslin (Rheinfelden, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a new pharmaceutical composition comprising Ceritinib. Particularly it is directed to the tablet that is prepared by wet granulation, wherein povidone is used as a binder. Further feature of the composition is that the drug and the binder form the inner phase, whereas all other excipients are added in a powder form as an outer phase. This way, the sticking of the composition is preve...